ZENAS BIOPHARMA, INC.
ZENAS BIOPHARMA, INC. is a registered legal entity registered in United States under 7578669, and its current status with Delaware Division of Corporations is active. The company was incorporated on 8 February 2023 and lists its registered address as United States. 5 shareholders are on record for ZENAS BIOPHARMA, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Delaware Division of Corporations and was last updated on 4 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for ZENAS BIOPHARMA, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is SR One Capital Management, LP, holding 13.8% — the largest recorded stake — followed by Enavate Sciences Gp, LLC at 10.5%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 20 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| SR One Capital Management, LP | 13.8% | Delaware Division of Corporations | |
| Enavate Sciences Gp, LLC | 10.5% | Delaware Division of Corporations | |
| FMR, LLC | 9.3% | Delaware Division of Corporations | |
| NEA Management Company, LLC | 7.7% | Delaware Division of Corporations | |
| Novo Holdings A/S | 6.3% | Delaware Division of Corporations |
Officers
5
The Ceo & Chairman Of The Board of ZENAS BIOPHARMA, INC. currently on record is Leon Oliver Moulder Jr., M.b.a.; five officers are currently on record for ZENAS BIOPHARMA, INC., filed with Delaware Division of Corporations.
The register reports 9 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at ZENAS BIOPHARMA, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
ZENAS BIOPHARMA, INC. has no recorded parent company — it sits at the top of its own group structure, with 4 subsidiaries recorded beneath it across 4 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 4 subsidiaries span United States, Hong Kong, Germany, Netherlands jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 4 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
ZENAS BIOPHARMA, INC.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns ZENAS BIOPHARMA, INC.?
Five shareholders are currently on record for ZENAS BIOPHARMA, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is SR One Capital Management, LP, holding 13.8% — the largest recorded stake — followed by Enavate Sciences Gp, LLC at 10.5%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is ZENAS BIOPHARMA, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for ZENAS BIOPHARMA, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does ZENAS BIOPHARMA, INC. have on record?
5 shareholders are shown on record for ZENAS BIOPHARMA, INC.. The register reports 20 in total; only the top 5 by holding are shown here.
What is ZENAS BIOPHARMA, INC.'s company registration number?
ZENAS BIOPHARMA, INC.'s registration number is 7578669, filed with Delaware Division of Corporations in United States. Its current status on the register is active.
Is ZENAS BIOPHARMA, INC. still an active company?
ZENAS BIOPHARMA, INC.'s status on Delaware Division of Corporations is listed as active.
When was ZENAS BIOPHARMA, INC. incorporated?
ZENAS BIOPHARMA, INC. was incorporated on 8 February 2023, according to Delaware Division of Corporations.
What is ZENAS BIOPHARMA, INC.'s registered address?
The registered address on file for ZENAS BIOPHARMA, INC. is United States.
Who are the officers/directors of ZENAS BIOPHARMA, INC.?
The Ceo & Chairman Of The Board of ZENAS BIOPHARMA, INC. currently on record is Leon Oliver Moulder Jr., M.b.a.; five officers are currently on record for ZENAS BIOPHARMA, INC., filed with Delaware Division of Corporations. Management authority at ZENAS BIOPHARMA, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does ZENAS BIOPHARMA, INC. have a parent company or subsidiaries?
ZENAS BIOPHARMA, INC. has no recorded parent company — it sits at the top of its own group structure, with 4 subsidiaries recorded beneath it across 4 jurisdictions. Those 4 subsidiaries span United States, Hong Kong, Germany, Netherlands jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear. One of the 4 go a level deeper still, with its own further subsidiaries recorded beneath it — additional ownership layers this view doesn't expand.
Can Zavia monitor changes to ZENAS BIOPHARMA, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from Delaware Division of Corporations. Zavia's monitoring API can track changes to ZENAS BIOPHARMA, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access ZENAS BIOPHARMA, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like ZENAS BIOPHARMA, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Delaware Division of Corporations and was last synced on 4 October 2026.